TESTBANK
PharmacotherapeuticsforAdvancedPracticeNursePrescribers,6thEdition
Author:Teri Moser
RFSXSOKM Wooand
RFSXSOKM WendyL.
RFSXSOKM Wright
RFSXSOKM
, TABLE OF CONTENT
RFSXSOKM RFSXSOKM
Chapter1.TheRoleoflthelAdvancedPracticelNurselasRFSXSOKMPrescriber .................................................................... 4
Chapter2.ReviewoflBasiclPrinciplesRFSXSOKMofPharmacology ..................................................................................... 5
Chapter3.RationalDruglSelection ......................................................................................................................... 11
Chapter4.LegalRFSXSOKMandProfessionalRFSXSOKMIssuesinPrescribing .............................................................................. 14
Chapter5.AdverselDruglReactions ........................................................................................................................ 16
Chapter6.RFSXSOKMAnRFSXSOKMIntroductiontoPharmacogenomics ...................................................................................... 19
Chapter7.NutritionandNutraceuticals .................................................................................................................. 22
Chapter8.HerbalTherapies ................................................................................................................................... 28
Chapter9.Cannabis............................................................................................................................................... 31
Chapter10.Pharmacoeconomics ........................................................................................................................... 35
Chapter11.DrugsAffectingthelAutonomicNervousSystem ................................................................................... 38
Chapter12.DrugsAffectingthelCentralNervousSystem ......................................................................................... 45
Chapter13.DrugsAffectingthelCardiovascularandRenalR F S X S O K M R F S X S O K M Systems ............................................. 53
Chapter14.DrugsAffectingthelRespiratorySystem ............................................................................................... 61
Chapter15.DrugsAffectingthelHematologicalSystem........................................................................................... 65
Chapter16.DrugsAffectingthelImmuneSystem:VaccinesandR F S X S O K M R F S X S O K M Immunoglobulins.................... 69
Chapter17.DrugsAffectingthelImmuneSystem:R F S X S O K M Immunomodulators ............................................. 75
Chapter18.DrugsAffectingthe lGastrointestinalRFSXSOKMSystem ............................................................................... 77
Chapter19.DrugsAffectingtheEndocrineSystem:PancreaticHormonesandAntidiabeticDrugs.............................. 80
Chapter20.DrugsAffectingthelEndocrineSystem:Pituitary,Thyroid,andlAdrenalR F S X S O K M R F S X S O K M Drugs ..... 83
Chapter21.DrugsAffectingthelReproductivelSystem ............................................................................................ 86
Chapter22.DrugsAffectingthelBonesandlJoints .................................................................................................... 92
Chapter23.DrugsAffectingthelIntegumentarySystem ........................................................................................... 96
Chapter24.DrugsUsedtolTreatRFSXSOKMBacterialRFSXSOKMInfections ...............................................................................101
Chapter25.DrugsUsedtolTreatRFSXSOKMViral,Fungal,RFSXSOKMandProtozoalRFSXSOKMInfections ...........................................105
Chapter26.DrugsUsedtolTreatR F S X S O K M InflammatoryProcesses.....................................................................108
Chapter27.DrugsUsedtolTreatR F S X S O K M EyelandEarDisorders .........................................................................111
Chapter28.Anemia ..............................................................................................................................................113
Chapter29.AnxietyandDepression ......................................................................................................................116
Chapter30.AttentionDeficit-HyperactivityDisorder ...........................................................................................120
Chapter31.AsthmaandRFSXSOKMAllergy .....................................................................................................................122
Chapter32.ChronicObstructivelPulmonaryDisease .............................................................................................125
Chapter33.Contraception ....................................................................................................................................127
Chapter34.COVID-19:RFSXSOKMAcuteandChronic ....................................................................................................130
Chapter35.DermatologicalConditions.................................................................................................................134
Chapter36.DiabeteslManagement .......................................................................................................................138
Chapter37.GastroesophagealR F S X S O K M RefluxandPepticUlcerDisease ...................................................................146
Chapter38.Headaches .........................................................................................................................................149
Chapter39.HeartFailure ......................................................................................................................................153
Chapter40.HIVDiseaselandAcquiredR F S X S O K M ImmunodeficiencyR F S X S O K M Syndrome ............................................158
Chapter41.MenopausalHormoneTherapy ...........................................................................................................161
,Chapter42.Hyperlipidemia..................................................................................................................................164
Chapter43.Hypertension .....................................................................................................................................169
Chapter44.HyperthyroidismlandlHypothyroidism ...............................................................................................174
Chapter45.Obesity ..............................................................................................................................................177
Chapter46.PainManagement: RFSXSOKMAcutelandChronicPain ................................................................................181
Chapter47.Pneumonia ........................................................................................................................................185
Chapter48.SexuallyTransmitted RFSXSOKMDiseasesandVaginitis ..............................................................................187
Chapter49.SubstanceUseDisorders .....................................................................................................................190
Chapter50.Tuberculosis ......................................................................................................................................195
Chapter51.UpperRespiratoryTractInfection,Pharyngitis,Sinusitis,OtitisMedia,andlOtitislExterna ......................197
Chapter52.UrinaryTractlInfections ......................................................................................................................200
Chapter53.WomenlasRFSXSOKMPatients ......................................................................................................................203
Chapter54.MenlasRFSXSOKMPatients...........................................................................................................................207
Chapter55.PediatricPatients ................................................................................................................................209
Chapter57.GeriatricPatients ................................................................................................................................213
, Woo 1
PharmacotherapeuticsforAPNPrescribers,6e Ch01
Chapter 1.
RFSXSOKM The Role
RFSXSOKM l ofthe
RFSXSOKM RFSXSOKMAdvanced Practice Nurseas
RFSXSOKM l Prescriber
RFSXSOKM
MULTIPLECHOICE
1. Nurselpractitionerprescriptiveauthorityislregulatedby:
A. TheRFSXSOKMNationalRFSXSOKMCouncilofRFSXSOKMStateRFSXSOKMBoardsofNursing
B. TheU.S.RFSXSOKMDruglEnforcementRFSXSOKMAdministration
C. TheRFSXSOKMStateRFSXSOKMBoardofRFSXSOKMNursingforRFSXSOKMeachRFSXSOKMstate
D. TheStateRFSXSOKMBoardlofRFSXSOKMPharmacy
ANS:R F S X S O K M C PTS:R F S X S O K M 1
2. ThelbenefitstothelpatientofhavingRFSXSOKManRFSXSOKMadvancedpracticeregisterednursel(APRN)lprescriber
inclRFSXSOKMude:
A. NurseslknowmoreaboutlpharmacologythanotherprescribersbecausetheytakelitbotR F
S X S O K M hintheirbasicnursingprogramandlintheirRFSXSOKMAPRNprogram.
B. NurseslcarelforthepatientfromaholisticapproachandincludelthepatientindeciR F
S X S O K M sion-makingregardingltheircare.
C. APRNslarellesslikelytoprescribenarcoticsandothercontrolledsubstances.
D. APRNsarelableltoprescribeindependentlyinallstates,RFSXSOKMwhereasalphysician’sas
siRFSXSOKMstantneedsltohavelaphysicianlsupervisingtheirpractice.
ANS:R F S X S O K M B PTS:R F S X S O K M 1
3. Clinicaljudgmentinprescribinglincludes:
A. Factoringinlthelcosttolthelpatientlofthelmedicationprescribed
B. Alwayslprescribinglthelnewestmedicationavailablelforthediseaseprocess
C. Handingloutdruglsamplestopoorpatients
D. Prescribingallgenericlmedicationstolcutcosts
ANS:R F S X S O K M A PTS:R F S X S O K M 1
4. Theprocessforchoosing RFSXSOKManRFSXSOKMeffectivedrugforadisorderincludes:
A. Askingthepatientwhatdrugtheythinkwouldworkbestforthem
B. Consultingnationallyrecognizedlguidelinesfordiseaselmanagement
C. PrescribingmedicationsthatarelavailableRFSXSOKMasRFSXSOKMsamplesbeforewritinglaprescription
D. FollowingRFSXSOKMU.S.RFSXSOKMDrugRFSXSOKMEnforcementRFSXSOKMAdministrationRFSXSOKMguidelinesforprescribing
ANS:R F S X S O K M B PTS:R F S X S O K M 1
5. Nonintentionalnonadherence lofdrugtherapymayRFSXSOKMoccurdueto:
A. Beliefthatlmedicationdoesnotwork
B. Adversedrugreactions
C. ChronicconditionsRFSXSOKMthatrequireldailytherapy
D. Forgetfulnessordistraction
ANS:R F S X S O K M D PTS:R F S X S O K M 1
PharmacotherapeuticsforAdvancedPracticeNursePrescribers,6thEdition
Author:Teri Moser
RFSXSOKM Wooand
RFSXSOKM WendyL.
RFSXSOKM Wright
RFSXSOKM
, TABLE OF CONTENT
RFSXSOKM RFSXSOKM
Chapter1.TheRoleoflthelAdvancedPracticelNurselasRFSXSOKMPrescriber .................................................................... 4
Chapter2.ReviewoflBasiclPrinciplesRFSXSOKMofPharmacology ..................................................................................... 5
Chapter3.RationalDruglSelection ......................................................................................................................... 11
Chapter4.LegalRFSXSOKMandProfessionalRFSXSOKMIssuesinPrescribing .............................................................................. 14
Chapter5.AdverselDruglReactions ........................................................................................................................ 16
Chapter6.RFSXSOKMAnRFSXSOKMIntroductiontoPharmacogenomics ...................................................................................... 19
Chapter7.NutritionandNutraceuticals .................................................................................................................. 22
Chapter8.HerbalTherapies ................................................................................................................................... 28
Chapter9.Cannabis............................................................................................................................................... 31
Chapter10.Pharmacoeconomics ........................................................................................................................... 35
Chapter11.DrugsAffectingthelAutonomicNervousSystem ................................................................................... 38
Chapter12.DrugsAffectingthelCentralNervousSystem ......................................................................................... 45
Chapter13.DrugsAffectingthelCardiovascularandRenalR F S X S O K M R F S X S O K M Systems ............................................. 53
Chapter14.DrugsAffectingthelRespiratorySystem ............................................................................................... 61
Chapter15.DrugsAffectingthelHematologicalSystem........................................................................................... 65
Chapter16.DrugsAffectingthelImmuneSystem:VaccinesandR F S X S O K M R F S X S O K M Immunoglobulins.................... 69
Chapter17.DrugsAffectingthelImmuneSystem:R F S X S O K M Immunomodulators ............................................. 75
Chapter18.DrugsAffectingthe lGastrointestinalRFSXSOKMSystem ............................................................................... 77
Chapter19.DrugsAffectingtheEndocrineSystem:PancreaticHormonesandAntidiabeticDrugs.............................. 80
Chapter20.DrugsAffectingthelEndocrineSystem:Pituitary,Thyroid,andlAdrenalR F S X S O K M R F S X S O K M Drugs ..... 83
Chapter21.DrugsAffectingthelReproductivelSystem ............................................................................................ 86
Chapter22.DrugsAffectingthelBonesandlJoints .................................................................................................... 92
Chapter23.DrugsAffectingthelIntegumentarySystem ........................................................................................... 96
Chapter24.DrugsUsedtolTreatRFSXSOKMBacterialRFSXSOKMInfections ...............................................................................101
Chapter25.DrugsUsedtolTreatRFSXSOKMViral,Fungal,RFSXSOKMandProtozoalRFSXSOKMInfections ...........................................105
Chapter26.DrugsUsedtolTreatR F S X S O K M InflammatoryProcesses.....................................................................108
Chapter27.DrugsUsedtolTreatR F S X S O K M EyelandEarDisorders .........................................................................111
Chapter28.Anemia ..............................................................................................................................................113
Chapter29.AnxietyandDepression ......................................................................................................................116
Chapter30.AttentionDeficit-HyperactivityDisorder ...........................................................................................120
Chapter31.AsthmaandRFSXSOKMAllergy .....................................................................................................................122
Chapter32.ChronicObstructivelPulmonaryDisease .............................................................................................125
Chapter33.Contraception ....................................................................................................................................127
Chapter34.COVID-19:RFSXSOKMAcuteandChronic ....................................................................................................130
Chapter35.DermatologicalConditions.................................................................................................................134
Chapter36.DiabeteslManagement .......................................................................................................................138
Chapter37.GastroesophagealR F S X S O K M RefluxandPepticUlcerDisease ...................................................................146
Chapter38.Headaches .........................................................................................................................................149
Chapter39.HeartFailure ......................................................................................................................................153
Chapter40.HIVDiseaselandAcquiredR F S X S O K M ImmunodeficiencyR F S X S O K M Syndrome ............................................158
Chapter41.MenopausalHormoneTherapy ...........................................................................................................161
,Chapter42.Hyperlipidemia..................................................................................................................................164
Chapter43.Hypertension .....................................................................................................................................169
Chapter44.HyperthyroidismlandlHypothyroidism ...............................................................................................174
Chapter45.Obesity ..............................................................................................................................................177
Chapter46.PainManagement: RFSXSOKMAcutelandChronicPain ................................................................................181
Chapter47.Pneumonia ........................................................................................................................................185
Chapter48.SexuallyTransmitted RFSXSOKMDiseasesandVaginitis ..............................................................................187
Chapter49.SubstanceUseDisorders .....................................................................................................................190
Chapter50.Tuberculosis ......................................................................................................................................195
Chapter51.UpperRespiratoryTractInfection,Pharyngitis,Sinusitis,OtitisMedia,andlOtitislExterna ......................197
Chapter52.UrinaryTractlInfections ......................................................................................................................200
Chapter53.WomenlasRFSXSOKMPatients ......................................................................................................................203
Chapter54.MenlasRFSXSOKMPatients...........................................................................................................................207
Chapter55.PediatricPatients ................................................................................................................................209
Chapter57.GeriatricPatients ................................................................................................................................213
, Woo 1
PharmacotherapeuticsforAPNPrescribers,6e Ch01
Chapter 1.
RFSXSOKM The Role
RFSXSOKM l ofthe
RFSXSOKM RFSXSOKMAdvanced Practice Nurseas
RFSXSOKM l Prescriber
RFSXSOKM
MULTIPLECHOICE
1. Nurselpractitionerprescriptiveauthorityislregulatedby:
A. TheRFSXSOKMNationalRFSXSOKMCouncilofRFSXSOKMStateRFSXSOKMBoardsofNursing
B. TheU.S.RFSXSOKMDruglEnforcementRFSXSOKMAdministration
C. TheRFSXSOKMStateRFSXSOKMBoardofRFSXSOKMNursingforRFSXSOKMeachRFSXSOKMstate
D. TheStateRFSXSOKMBoardlofRFSXSOKMPharmacy
ANS:R F S X S O K M C PTS:R F S X S O K M 1
2. ThelbenefitstothelpatientofhavingRFSXSOKManRFSXSOKMadvancedpracticeregisterednursel(APRN)lprescriber
inclRFSXSOKMude:
A. NurseslknowmoreaboutlpharmacologythanotherprescribersbecausetheytakelitbotR F
S X S O K M hintheirbasicnursingprogramandlintheirRFSXSOKMAPRNprogram.
B. NurseslcarelforthepatientfromaholisticapproachandincludelthepatientindeciR F
S X S O K M sion-makingregardingltheircare.
C. APRNslarellesslikelytoprescribenarcoticsandothercontrolledsubstances.
D. APRNsarelableltoprescribeindependentlyinallstates,RFSXSOKMwhereasalphysician’sas
siRFSXSOKMstantneedsltohavelaphysicianlsupervisingtheirpractice.
ANS:R F S X S O K M B PTS:R F S X S O K M 1
3. Clinicaljudgmentinprescribinglincludes:
A. Factoringinlthelcosttolthelpatientlofthelmedicationprescribed
B. Alwayslprescribinglthelnewestmedicationavailablelforthediseaseprocess
C. Handingloutdruglsamplestopoorpatients
D. Prescribingallgenericlmedicationstolcutcosts
ANS:R F S X S O K M A PTS:R F S X S O K M 1
4. Theprocessforchoosing RFSXSOKManRFSXSOKMeffectivedrugforadisorderincludes:
A. Askingthepatientwhatdrugtheythinkwouldworkbestforthem
B. Consultingnationallyrecognizedlguidelinesfordiseaselmanagement
C. PrescribingmedicationsthatarelavailableRFSXSOKMasRFSXSOKMsamplesbeforewritinglaprescription
D. FollowingRFSXSOKMU.S.RFSXSOKMDrugRFSXSOKMEnforcementRFSXSOKMAdministrationRFSXSOKMguidelinesforprescribing
ANS:R F S X S O K M B PTS:R F S X S O K M 1
5. Nonintentionalnonadherence lofdrugtherapymayRFSXSOKMoccurdueto:
A. Beliefthatlmedicationdoesnotwork
B. Adversedrugreactions
C. ChronicconditionsRFSXSOKMthatrequireldailytherapy
D. Forgetfulnessordistraction
ANS:R F S X S O K M D PTS:R F S X S O K M 1
